Indications and uses
For the relief of tiredness and jet lag associated with flying
For the relief of tiredness and jet lag associated with flying
Age Dose Adults and Children 2 years and over Chew one tablet on each take-off, one about every two hours, and one after landing. However, intervals of up to four hours between tablets are acceptable if sleeping. Best taken separately from meals. Under 2 years Ask a doctor.
store under 86°F (30°C) No drug interactions Non-drowsy
Drug Facts
| Active Ingredients | Purpose | |
|---|---|---|
| Arnica Montana | 30C HPUS | To reduce jet lag |
| Bellis Perennis | 30C HPUS | |
| Chamomilla | 30C HPUS | |
| Ipecacuanha | 30C HPUS | |
| Lycopodium | 30C HPUS | |
The letters HPUS indicate that these ingredients are officially included in the Homeopathic Pharmacopeia of the United States.
For the relief of tiredness and jet lag associated with flying
Do not use if the blister pack is broken.
Ask a doctor before use in children under 2 years of age.
Stop use and ask a doctor if symptoms persist for more than 3 days or worsen.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
| Age | Dose |
|---|---|
| Adults and Children 2 years and over | Chew one tablet on each take-off, one about every two hours, and one after landing. However, intervals of up to four hours between tablets are acceptable if sleeping. Best taken separately from meals. |
| Under 2 years | Ask a doctor. |
Dextrose and separating agents magnesium stearate and silicon dioxide.
Distributed to retailers by
L.C. Industries, Inc
Elk Grove Village, IL 60007
Made in
New Zealand
The Perfect Travel Companion
NDC 59672-0130-4
NO-JET-LAG
®
Homeopathic Jet Lag Prevention
Safe • Natural • Effective • No Side Effects or Drug Interactions
Available in Australia, Canada, Hong Kong, New Zealand, Singapore, South Africa, UAE & USA
NET 32 TABLETS: SUFFICIENT FOR 50 HOURS OF FLYING

| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ed912195-5da0-0f2f-6f4b-3ef17710cbe3 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 59672-0130-4 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-efcc-f424-e053-dadaa90a57ce | NO-JET-LAG ® Homeopathic Jet Lag Prevention |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59672-0130-4 | NO-JET-LAG | 32 in 1 BLISTER PACK | TABLET | 32 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59672-0130 | NO-JET-LAG (ARNICA MONTANA, BELLIS PERENNIS, MATRICARIA RECUTITA, IPECAC, AND LYCOPODIUM CLAVATUM SPORE) TABLET [LC INDUSTRIES] | 3 | Legacy NDC, 1 package rows | 20140828_08c4538a-836e-4d14-9143-245a77346b23.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Arnica Montana | ACTIVE INGREDIENT | O80TY208ZW | 3 | |
| Bellis Perennis | ACTIVE INGREDIENT | 2HU33I03UY | 3 | |
| Ipecac | ACTIVE INGREDIENT | 62I3C8233L | 3 | |
| Lycopodium Clavatum Spore | ACTIVE INGREDIENT | C88X29Y479 | 3 | |
| Matricaria Recutita | ACTIVE INGREDIENT | G0R4UBI2ZZ | 3 | |
| Arnica Montana | ACTIVE MOIETY | O80TY208ZW | 3 | |
| Bellis Perennis | ACTIVE MOIETY | 2HU33I03UY | 3 | |
| Ipecac | ACTIVE MOIETY | 62I3C8233L | 3 | |
| Lycopodium Clavatum Spore | ACTIVE MOIETY | C88X29Y479 | 3 | |
| Matricaria Recutita | ACTIVE MOIETY | G0R4UBI2ZZ | 3 | |
| Dextrose | INACTIVE INGREDIENT | IY9XDZ35W2 | 3 | |
| Magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | 3 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59672-0130 | 59672-0130-4 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Arnica Montana | O80TY208ZW | ACTIB |
| Bellis Perennis | 2HU33I03UY | ACTIB |
| Matricaria Recutita | G0R4UBI2ZZ | ACTIB |
| Ipecac | 62I3C8233L | ACTIB |
| Lycopodium Clavatum Spore | C88X29Y479 | ACTIB |
| Dextrose | IY9XDZ35W2 | IACT |
| silicon dioxide | ETJ7Z6XBU4 | IACT |
| Magnesium stearate | 70097M6I30 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | GRANULE / ORAL | 629 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / SUBLINGUAL | 10 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, DELAYED RELEASE / ORAL | 3.2 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | TABLET / ORAL | 183.66 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | CONCENTRATE / ORAL | 400 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | 106 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | TABLET, EXTENDED RELEASE / ORAL | 103.95 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | TROCHE / ORAL | 903.5 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, EXTENDED RELEASE / ORAL | 117 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE / ORAL | 1190 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | WAFER / ORAL | 66 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SOLUTION / ORAL | 1.8 mg/120ml | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / SUBCUTANEOUS | 0.5 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FOR SUSPENSION / ORAL | 131 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | TABLET, DELAYED RELEASE / ORAL | NA | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUPPOSITORY / RECTAL | 14 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | PASTE / DENTAL | 34 %w/w | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / DENTAL | 19 %w/w | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | TABLET, COATED / ORAL | 132 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / ORAL | 420 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, EXTENDED RELEASE / ORAL | 168 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | PELLET / ORAL | 34 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING / ORAL | 187 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / TRANSMUCOSAL | 100 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | INJECTION, SOLUTION / INTRATHECAL | 1925 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION / ORAL | 400 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | POWDER, FOR SOLUTION / ORAL | NA | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SOLUTION / ORAL | 280 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | SOLUTION / ORAL | 2489 mg/5ml | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER / RESPIRATORY (INHALATION) | 0.13 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 47 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / ORAL | 300 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TROCHE / ORAL | 315 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / INTRAVITREAL | NA | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | INJECTION / INTRASPINAL | 75 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | LOZENGE / ORAL | 120 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION, EXTENDED RELEASE / ORAL | 71 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 2 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FOR SUSPENSION / ORAL | 220 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | SOLUTION / INTRAVENOUS | 5.05 %w/v | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, SOLUBLE / ORAL | 2 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | INSERT / VAGINAL | 69 mg | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 53 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING / ORAL | 68 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 336 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE / ORAL | 5000 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, EXTENDED RELEASE / ORAL | 450 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SUSPENSION / ORAL | 2553 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, EXTENDED RELEASE / TRANSDERMAL | 49 mg | ||
| Dextrose | DEXTROSE | IY9XDZ35W2 | TABLET / SUBLINGUAL | 115.78 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER / TOPICAL | 104 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | DROPS / ORAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0055b112-9820-4fad-b7e0-58264b97fb60 | 08c4538a-836e-4d14-9143-245a77346b23 | 2014-08-14 | Warnings | 0055b112-9820-4fad-b7e0-58264b97fb60 08c4538a-836e-4d14-9143-245a77346b23 |
Adverse event summaries are temporarily unavailable. Other product information remains available.